Centers

EU-OPENSCREEN

FDA Oncology Center of Excellence Project Catalyst

Chulalongkorn University Drug Discovery and Drug Development Research Center (Chula4DR)

EU-OPENSCREEN is a multinational, not-for-profit initiative, which integrates high-capacity screening platforms and chemistry groups across Europe. The aim of this initiative is to support individual scientists interested in chemical biology...
Read more

Providing a regulatory platform to connect scientific knowledge, creative insight, and medical professionals to foster early-stage product innovation

Read more
Chulalongkorn Drug Discovery and Drug Development Research Center (Chula4DR) was established in 2017, with the aim to facilitate advancement of academic drug discovery and drug development research by leveraging innovations and sciences...
Read more

Partnerships

Events

Jobs

Janssen Pharmaceuticals and Johns Hopkins To Develop New Therapies to Treat Neurological Diseases

Janssen Pharmaceuticals (Formerly OMJPI) a Johnson and Johnson entity has entered into collaboration agreement with Johns Hopkins Brain Science Institute ("BSi") at Johns Hopkins University. Janssen will be working with Johns Hopkins researchers...

 
View all

Sanofi to Collaborate with UCSF to Develop New Drugs to Treat Diabetes

University of California, San Francisco (UCSF) has entered into a broad collaboration agreement with Sanofi to develop new therapies to treat Diabetes (Type 1 & 2). Scientists with deep biology expertise at Sanofi will be partnering with...

 
View all

California Institute for Quantitative Biosciences (QB3)

 QB3 isa tri-campus organization at UC Berkeley, UC San Francisco, and UC Santa Cruz.

QB3 is the University of California’s hub for innovation and entrepreneurship in the life sciences. The institute supports UC researchers and empowers...

 
View all

No EVENTS for listing

No Job Posts

Sponsors

Pfizer Roche HL Tocris Sigma-Aldrich Xenotech Xenotech Eurofins Pfizer Roche HL Tocris Sigma-Aldrich Xenotech Xenotech Eurofins
View All